870P Potential assessment of radiomic PET in the evaluation of cervical cancer treatment

To investigate possible value of radiomic FDG PET analysis in the assessment of neoadjuvant chemotherapy response and post-surgery decision-making in locally advanced cervical cancer (LACC). We evaluated women with LACC, treated with cisplatin neoadjuvant chemotherapy (NACT) at our Institute, between 2014-2018, classified as Ib3-IIb clinical FIGO. MRI was performed to evaluate NACT response and plan radical surgery. RECIST1.1 were applied to MRI...